Plain-English translation of NCT07071272 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer type of mammography called contrast-enhanced digital mammography (CEDM) works just as well as an MRI scan for detecting and staging breast cancer before surgery. Both imaging methods use contrast dye to help visualize cancer, but CEDM may be faster, cheaper, and available to more patients—including those who cannot have an MRI. Researchers will compare how accurately each method identifies cancer by checking results against tissue samples taken during surgery.
MRI scans are considered the gold standard for detailed breast cancer staging but are expensive, take a long time, and many patients cannot have them due to pacemakers or claustrophobia. This trial exists to see if the newer CEDM technique can do the same job more practically and affordably for patients preparing for surgery.
You likely qualify if…
You likely don't qualify if…
You would receive both an MRI scan and a contrast-enhanced mammogram during scheduled visits. If you are in the chemotherapy group, you would also have these same imaging scans repeated at 3 and 6 months to track how the cancer is responding to treatment. After surgery or treatment, your imaging results will be compared to the actual tissue samples from your biopsy or surgery to see which imaging method was more accurate.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy